Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
2
Mar 11, 2013 11:22AM
Share
New Message
Please login to post a reply